Ironwood Pharmaceuticals Statistics
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.91+0.16 (+4.27%)
Market open · Delayed 15 min · as of Oct 8, 3:17 PM ET
Ironwood Pharmaceuticals by the numbers
Ironwood Pharmaceuticals has a market capitalization of $646.1 million based on 165.24M shares outstanding. Its trailing P/E ratio is 5.1, and its forward P/E is 2.6. The stock trades 5.9% below its 50-day average and 2.3% below its 200-day average.
Average daily trading volume is 2.03M shares, or about $7.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IRWD valuation vs. peer median
| Metric | IRWD | Peer median | Difference |
|---|---|---|---|
| Market cap | $646.09M | $630.94M | +2% |
| Avg. volume | 2.03M | 1.22M | +67% |
Peer median across 8 companies: CLYM, SGMT, AQST, ABUS, ZVRA, SLN, STTK, NVCT.
Valuation
- Market cap
- $646.09M
- P/E (TTM)
- 5.08
- Forward P/E
- 2.61
- EPS (TTM)
- $0.77
- Shares outstanding
- 165.24M
Price and trading
- Previous close
- 3.75
- Open
- 3.70
- Day range
- 3.67 – 3.97
- 52-week range
- 1.41 – 5.78
- 52-week change
- +146.71%
- Beta
- —
- Volume
- 1.22M
- Average volume
- 2.03M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 646.09M
- Pe
- 5.08
- Forward Pe
- 2.61
- Eps
- 0.77
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.78
- Week52 Low
- 1.41
- Avg Volume
- 2.03M
- Shares Outstanding
- 165.24M
- Ma50
- 4.15
- Ma200
- 4.00
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -32.35%
- Pct From52w Low
- 177.30%